Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ADVR:THE NEW COMPANY...WITH A NEW LIFE...AND A NEW MISSION -- Ignore unavailable to you. Want to Upgrade?

To: JustMy2Cents who wrote (3963)	5/13/1999 11:08:00 AM
From: WayHaw	Read Replies (1) \| Respond to of 4891

"... The award of another patent reflects the breadth of potential applications of our peptide-nucleic acid type drugs," commented Dr. Shalom Z. Hirschman..." We're talking plural, folks!

To: JustMy2Cents who wrote (3963)	5/13/1999 11:12:00 AM
From: Kingfisher	Read Replies (1) \| Respond to of 4891

IMHO, it is apparent that Dr. Hirschman was forced to put out a news release this morning simply because of the US Patent Office announcement. Further, it appears that he decided to put out an innocuous release and to expend minimal effort and thought in doing so.. If Dr. Hirschman was truly supportive of the investment of ADVR shareholders and the value of the stock in light of potential option holder funds, he could have honestly embellished the announcement with some indications as to the other patent applications that are already implied and/or embedded in the ADVR's SEC documents. THANKS FOR THE SUPPORT DOC!!!